Received May 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
the pharmacy injected him first with the Adjuvant suspension by itself without reconstituting with the Antigen vial; the pharmacy injected him first with the Adjuvant suspension by itself without reconstituting with the Antigen vial; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: the pharmacy injected him first with the Adjuvant suspension by itself without reconstituting with the Antigen vial) and inappropriate dose of vaccine administered (Verbatim: the pharmacy injected him first with the Adjuvant suspension by itself without reconstituting with the Antigen vial). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 12-MAY-2025 The reporter reported that while getting the Shingrix vaccine, the pharmacy injected him first with the adjuvant suspension by itself without reconstituting with the antigen vial, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The pharmacy then noted the mistake and administered him the reconstituted vaccine.